Predict your next investment

Optimus company logo
HEALTHCARE | Pharmaceuticals / Drugs
optimuspharma.com

See what CB Insights has to offer

Total Raised

$16.5M

Investors Count

1

Deal Terms

1

Optimus Funding, Optimus Valuation & Optimus Revenue

1 Fundings

Optimus's latest funding round was a Corporate Minority for $16.5M on November 5, 2018.

Optimus's latest post-money valuation is from November 2018.

Sign up for a free 30-day trial to see Optimus's valuations in November 2018 and more.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

11/5/2018

Corporate Minority

$16.5M

$99M

$0.00B

((9.99x))

FY 1234

2

Date

11/5/2018

Round

Corporate Minority

Amount

$16.5M

Investors

Valuation

$99M

Revenue

$0.00B

((9.99x))

FY 1234

Sources

2

Optimus Deal Terms

1 Deal Term

Optimus's deal structure is available for 1 funding round, including their Corporate Minority from November 05, 2018.

Round

Corporate Minority

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Corporate Minority

Optimus Investors

1 Investors

Optimus has 1 investors. Unichem Labs invested in Optimus's Corporate Minority funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

11/5/2018

11/5/2018

1
Corporate Minority

Corporation

India

First funding

11/5/2018

Last Funding

11/5/2018

Investor

Rounds

1
Corporate Minority

Board Seats

Type

Corporation

Location

India

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.